Buscar | Webyourself Social Media Platform

agrega un archivo Health

2024-05-28 12:05:28 -

Dyspareunia Treatment Market: Current Trends and Future Prospects

Topical estrogen applied directly to the vagina is the main treatment for dyspareunia caused by low estrogen levels. The Food and Drug Administration has approved the drug ospemifene, commonly marketed as Osphena, to treat moderate to severe dyspareunia in women who have trouble lubricating their vagina. Opemifene behaves much like estrogen in the vaginal lining. The Dyspareunia Treatment...

0 Commentarios 0 Acciones 504 Views 0 Vista previa